Table 1 Antifungal therapy in cryptococcal meningitis
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement From: Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy Nature Reviews Neurology (Nat Rev Neurol) ISSN 1759-4766 (online) ISSN 1759-4758 (print) © 2022 Springer Nature Limited
Table 1 Antifungal therapy in cryptococcal meningitis | Nature Reviews Neurology Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement Stage Pharmacological treatment regimen Duration Induction L-AmB 3–6 mg/kg daily or D-AmB 0.7–1.0 mg/kg daily (L-AmB preferred in organ transplant pat
related reading
- Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy | Nature Reviews Neurologynature.com
- Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexatencbi.nlm.nih.gov
- Treatment and prevention of Pneumocystis infection in patients with HIVuptodate.com
- Guidance for Industryfda.gov
- Case Study: The Clinical Translation of Transcranial Magnetic Stimulationmilan.cvitkovic.net
- CNeuro2026 | CNeurocneuro.net
- Levofloxacin - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Overview of immune reconstitution inflammatory syndromesuptodate.com
- Exploring the barriers to the antiretroviral therapy adherence among people living with HIV in Bangladesh: A qualitative approachpmc.ncbi.nlm.nih.gov
- Première rémission durable de l’infection par le VIH après greffe de moelle en l’absence de mutation protectrice | Pour chaque vie, la science agitpasteur.fr
- Chorioretinitis - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Notionnotion.so